The 14-acre beachfront spread on Meadow Lane in Southampton, N.Y., was assembled from four parcels of land and includes several homes.
l.i.v. medical hydration therapy pLLC
312 noyac road
southampton, new york, 11968
NYS Entity Status
NYS Filing Date
AUGUST 26, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC PROFESSIONAL SERVICE LIMITED LIABILITY COMPANY
2014 - L.I.V. MEDICAL HYDRATION THERAPY PLLC
Around the Web
- Hamptons Property Asks $150 Million
Thursday Jul 13, 2017
- Shinnecock Hills gets longer, more strategic for 2018 U.S. Open
By Bradley S. Klein - Wednesday Oct 4, 2017
SOUTHAMPTON, N.Y – When the world’s best players tee it up here for the 2018 U.S. Open June 14-18, they’ll confront a golf (...)
- FDA approves 1st gene therapy treatment for cancer
By Catherine Ho - Wednesday Aug 30, 2017
The Food and Drug Administration on Wednesday approved the first gene therapy treatment for cancer, green-lighting Novartis Pharmaceuticals’ cell therapy treatment for childhood leukemia. The regulatory approval had been widely expected but came earlier than analysts’ predictions. It signals that other drug companies developing cell-therapy treatments may also be able to commercialize what medical experts say is a revolutionary new form of medicine. The therapy extracts a patient’s cells from his or her blood, sends them to a manufacturing site to genetically modify them, and then re-infuses them into the person’s body to attack cancer cells.
- Menopausal Hormone Therapy and Long-Term All-Cause and Cause-Specific Mortality
Tuesday Oct 10, 2017
Each month we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing updates in the fields of medicine and healthcare.
- Parents of Charlie Gard, Ill British Infant, Abandon Effort to Prolong His Life
By DAN BILEFSKY - Monday Jul 24, 2017
His parents accepted medical experts’ consensus that there was no realistic hope that an experimental therapy might save their son.
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]